LEGN

Legend Biotech Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 6/10
  • Value↓ 1/10
Legend Biotech sales and earnings growth
LEGN Growth
Good
  • Revenue Y/Y↑ 64.02%
  • EPS Y/Y↓ -68.75%
  • FCF Y/Y↑ 21.31%
Legend Biotech gross and profit margin trends
LEGN Profitability
Neutral
  • Gross margin ↑ 60.30%
  • EPS margin↓ -28.80%
  • ROIC 5Y↓ -57.27%
Legend Biotech net debt vs free cash flow
LEGN Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -12.2

Legend Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗